Ask AI
Donald Moore

Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP

Clinical Oncology Pharmacy Manager
Atrium Health Levine Cancer Institute
Charlotte, North Carolina

Explore Activities by Donald Moore

Title
Format
Credit Type
Credits
FAQs Regarding Later-Generation TKIs for Frontline Treatment of Chronic-Phase CML

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expert Insights for Hematology/Oncology Pharmacists on Later-Generation TKIs as Frontline Therapy in Chronic-Phase CML

Content Format:

Video

Credit Type:

ACPE-P

Credits:

1.00
Expert Insights for Hematology/Oncology Pharmacists on Later-Generation TKIs as Frontline Therapy in Chronic-Phase CML

Content Format:

Video

Credit Type:

ACPE-P

Credits:

1.00
The Role of the Hematology Pharmacist in CP-CML: Brief Overview on Individualizing Frontline Therapy, Risk Assessment, and Monitoring

Content Format:

Slideset

Credit Type:

--

Credits:

--
Optimizing Use of BTK Inhibitors in CLL/SLL and MCL for Managed Care Professionals

Content Format:

Slideset

Credit Type:

--

Credits:

--
Our Thoughts on Cytokine Release Syndrome With BCMA-Targeted Therapies for Relapsed/Refractory Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Integrating BCMA-Targeted Therapies Into R/R Multiple Myeloma Care: Opportunities for Pharmacists

Content Format:

Video

Credit Type:

ACPE-P

Credits:

1.00
Integrating BCMA-Targeted Therapies Into R/R Multiple Myeloma Care: Opportunities for Pharmacists

Content Format:

Slideset

Credit Type:

--

Credits:

--
How We Are Integrating New Data Into Relapsed/Refractory Myeloma Treatment

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Navigating a Rapidly Evolving Treatment Landscape for Relapsed/Refractory Myeloma: Integrating the Latest Data to Transform Care

Content Format:

Slideset Download

Credit Type:

--

Credits:

--